Search research articles
Contact Us
Filters
Showing results (211-220 of 235) with videos related to
Page
of 24
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2021
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
Luis G Paz-Ares, Suresh S Ramalingam, Tudor-Eliade Ciuleanu, et al.
Cancer Discovery
|
March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
Matthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.
Journal of the National Cancer Institute
|
November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
Joshua K Sabari, Michael Offin, Dennis Stephens, et al.
Cancer Cell
|
June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunity
Andrew Chow, Sara Schad, Michael D Green, et al.
Cell
|
October 10, 2020
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K Wells, Marit M van Buuren, Kristen K Dang, et al.
JAMA Oncology
|
June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
Science (New York, N.Y.)
|
November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Nature Genetics
|
April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2023
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]
D M Vega, L M Yee, L M McShane, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 235) with videos related to
Sort By:
Page
of 24
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2021
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
Luis G Paz-Ares, Suresh S Ramalingam, Tudor-Eliade Ciuleanu, et al.
Cancer Discovery
|
March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
Matthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.
Journal of the National Cancer Institute
|
November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
Joshua K Sabari, Michael Offin, Dennis Stephens, et al.
Cancer Cell
|
June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunity
Andrew Chow, Sara Schad, Michael D Green, et al.
Cell
|
October 10, 2020
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K Wells, Marit M van Buuren, Kristen K Dang, et al.
JAMA Oncology
|
June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
Science (New York, N.Y.)
|
November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Nature Genetics
|
April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2023
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]
D M Vega, L M Yee, L M McShane, et al.
Page
of 24